Literature DB >> 25706840

Drug-resistance mechanisms and tuberculosis drugs.

Claudio U Köser1, Babak Javid2, Kathleen Liddell3, Matthew J Ellington4, Silke Feuerriegel5, Stefan Niemann6, Nicholas M Brown4, William J Burman7, Ibrahim Abubakar8, Nazir A Ismail9, David Moore10, Sharon J Peacock11, M Estée Török12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25706840      PMCID： PMC4374148          DOI： 10.1016/S0140-6736(14)62450-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  Impact of Fgd1 and ddn diversity in Mycobacterium tuberculosis complex on in vitro susceptibility to PA-824.

Authors:  Silke Feuerriegel; Claudio U Köser; Davide Baù; Sabine Rüsch-Gerdes; David K Summers; John A C Archer; Marc A Marti-Renom; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.

Authors:  Wanliang Shi; Xuelian Zhang; Xin Jiang; Haiming Yuan; Jong Seok Lee; Clifton E Barry; Honghai Wang; Wenhong Zhang; Ying Zhang
Journal:  Science       Date:  2011-08-11       Impact factor: 47.728

3.  A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Authors:  Koen Andries; Peter Verhasselt; Jerome Guillemont; Hinrich W H Göhlmann; Jean-Marc Neefs; Hans Winkler; Jef Van Gestel; Philip Timmerman; Min Zhu; Ennis Lee; Peter Williams; Didier de Chaffoy; Emma Huitric; Sven Hoffner; Emmanuelle Cambau; Chantal Truffot-Pernot; Nacer Lounis; Vincent Jarlier
Journal:  Science       Date:  2004-12-09       Impact factor: 47.728

Review 4.  Drug resistance and antiretroviral drug development.

Authors:  Robert W Shafer; Jonathan M Schapiro
Journal:  J Antimicrob Chemother       Date:  2005-04-21       Impact factor: 5.790

5.  Multidrug-resistant tuberculosis and bedaquiline.

Authors:  Max Salfinger; Akos Somoskövi
Journal:  N Engl J Med       Date:  2014-12-18       Impact factor: 91.245

6.  Genetic rights and wrongs.

Authors: 
Journal:  Nature       Date:  2014-09-11       Impact factor: 49.962

Review 7.  Rationale and uses of a public HIV drug-resistance database.

Authors:  Robert W Shafer
Journal:  J Infect Dis       Date:  2006-09-15       Impact factor: 5.226

8.  Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance.

Authors:  Luiz Pedro S de Carvalho; Gang Lin; Xiuju Jiang; Carl Nathan
Journal:  J Med Chem       Date:  2009-10-08       Impact factor: 7.446

9.  Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor.

Authors:  E Huitric; P Verhasselt; A Koul; K Andries; S Hoffner; D I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

10.  The next controversy in genetic testing: clinical data as trade secrets?

Authors:  Robert Cook-Deegan; John M Conley; James P Evans; Daniel Vorhaus
Journal:  Eur J Hum Genet       Date:  2012-11-14       Impact factor: 4.246
View more
  8 in total

1.  Transmitted Extended-Spectrum Extensively Drug-Resistant Tuberculosis in Beijing, China, with Discordant Whole-Genome Sequencing Analysis Results.

Authors:  Hao Li; Masood ur Rehman Kayani; Yunting Gu; Xiaobo Wang; Ting Zhu; Hongfei Duan; Yifeng Ma; Hairong Huang; Babak Javid
Journal:  J Clin Microbiol       Date:  2015-06-10       Impact factor: 5.948

2.  Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.

Authors:  Suha Kadura; Nicholas King; Maria Nakhoul; Hongya Zhu; Grant Theron; Claudio U Köser; Maha Farhat
Journal:  J Antimicrob Chemother       Date:  2020-08-01       Impact factor: 5.790

3.  Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST.

Authors:  Peter M Keller; Rico Hömke; Claudia Ritter; Giorgia Valsesia; Guido V Bloemberg; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2015-05-04       Impact factor: 5.191

4.  Target regimen profiles for treatment of tuberculosis: a WHO document.

Authors:  Christian Lienhardt; Payam Nahid; Michael L Rich; Cathy Bansbach; Emily A Kendall; Gavin Churchyard; Lice González-Angulo; Lia D'Ambrosio; Giovanni Battista Migliori; Mario Raviglione
Journal:  Eur Respir J       Date:  2017-01-25       Impact factor: 16.671

5.  A Nano-MgO and Ionic Liquid-Catalyzed 'Green' Synthesis Protocol for the Development of Adamantyl-Imidazolo-Thiadiazoles as Anti-Tuberculosis Agents Targeting Sterol 14α-Demethylase (CYP51).

Authors:  Sebastian Anusha; Baburajeev Cp; Chakrabhavi Dhananjaya Mohan; Jessin Mathai; Shobith Rangappa; Surender Mohan; Shardul Paricharak; Lewis Mervin; Julian E Fuchs; Mahedra M; Andreas Bender; Kanchugarakoppal S Rangappa
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

6.  Molecular Characterization of Prothionamide-Resistant Mycobacterium tuberculosis Isolates in Southern China.

Authors:  Yaoju Tan; Biyi Su; Huiwen Zheng; Yuanyuan Song; Yufeng Wang; Yu Pang
Journal:  Front Microbiol       Date:  2017-11-30       Impact factor: 5.640

7.  Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays.

Authors:  Adebisi Ajileye; Nataly Alvarez; Matthias Merker; Timothy M Walker; Suriya Akter; Kerstin Brown; Danesh Moradigaravand; Thomas Schön; Sönke Andres; Viola Schleusener; Shaheed V Omar; Francesc Coll; Hairong Huang; Roland Diel; Nazir Ismail; Julian Parkhill; Bouke C de Jong; Tim E A Peto; Derrick W Crook; Stefan Niemann; Jaime Robledo; E Grace Smith; Sharon J Peacock; Claudio U Köser
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

8.  Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex.

Authors:  Matthias Merker; Thomas A Kohl; Ivan Barilar; Sönke Andres; Philip W Fowler; Erja Chryssanthou; Kristian Ängeby; Pontus Jureen; Danesh Moradigaravand; Julian Parkhill; Sharon J Peacock; Thomas Schön; Florian P Maurer; Timothy Walker; Claudio Köser; Stefan Niemann
Journal:  Genome Med       Date:  2020-03-06       Impact factor: 11.117
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.